[1]
O. Yonal, F. Eren, Y. Yılmaz, Özlen Atuğ, and H. Hamzaoğlu Över, “No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects”, Turkish Journal of Gastroenterology, vol. 25, no. 6, pp. 639–643, Jan. 2014.